ROCK Inhibition – A New Therapeutic Avenue in Kidney Protection

作者: Stefan Reuter , Dominik Kentrup , Eckhart Bussemaker

DOI: 10.5772/19200

关键词: ROCK2MedicineRho-associated protein kinaseKidneyVascular smooth muscle contractionChronic allograft nephropathyKinaseROCK1Cancer researchProtein kinase C

摘要: Chronic allograft nephropathy (CAN) remains the main cause of renal transplant loss besides death patients with a functioning graft. Its prevention and treatment still lacks any significant breakthrough since many years (Meier-Kriesche et al. 2004; Pascual 2002). Pathological manifestations CAN include interstitial fibrosis, tubular atrophy, vascular occlusive changes, glomerulosclerosis progressive dysfunction accompanied by hypertension proteinuria (Joosten 2005; Racusen 1999). This histopathologic constellation is now more formally descriptively referred to as fibrosis atrophy (IF/TA) without evidence specific aetiology (Solez 2007). IF/TA or describe common final path different injuries causing damage, whereas their precise pathogenesis complex only incompletely understood 2005). The process encompasses multifactorial aetiologies including alloantigen-dependent well alloantigen-independent factors (Gottmann 2003; Joosten Kerjaschki 2006; Nankivell Reuter 2010; Tullius & Tilney, 1995). Hence, an effective not available so far. Rho effectors Rho-associated, coiled-coil containing protein kinases (ROCK) associated signaling pathways have emerged important players in cardiovascular pathophysiology. Recently, it has been shown that ROCK inhibition protective diabetic obstructive nephropathy, hypertensive nephrosclerosis, ischemia reperfusion injury, chronic (Kanda 2003a; Kentrup D. 10 A.D.; Komers 2011a; 2011b; Liu 2009; Nagatoya 2002; Nishikimi 2004a; Satoh Song 2008; Versteilen 2011). ROCKs initially identified downstream targets small GTP binding Rho. Members family (isoforms A–E, G), Rac 1 2), Cdc42 TC10 (Nobes Hall, 1994). After translocation plasma membrane, GTP-RhoA activates its effectors, two isoforms ROCK, ROCK1 (ROK┚, p160ROCK) ROCK2 (ROK┙, kinase) (Nakagawa 1996). Although, 2 can be differentially regulated under distinct circumstances there no functions at present are serine/threonine belonging AGC (PKA/PKG/PKC) (Ishizaki 1996; Leung 1995; Matsui activity involved actin cytoskeletal organization, stress fiber formation, cell contraction thereby controlling smooth muscle contraction, endothelial barrier leukocyte (e.g., cellular

参考文章(180)
Aya Takesono, Sarah J. Heasman, Beata Wojciak-Stothard, Ritu Garg, Anne J. Ridley, Microtubules Regulate Migratory Polarity through Rho/ROCK Signaling in T Cells PLoS ONE. ,vol. 5, pp. e8774- ,(2010) , 10.1371/JOURNAL.PONE.0008774
Brian J. Nankivell, Richard J. Borrows, Caroline L.-S. Fung, Philip J. O'Connell, Richard D.M. Allen, Jeremy R. Chapman, The natural history of chronic allograft nephropathy. The New England Journal of Medicine. ,vol. 349, pp. 2326- 2333 ,(2003) , 10.1056/NEJMOA020009
Midoriko Higashi, Hiroaki Shimokawa, Tsuyoshi Hattori, Junko Hiroki, Yasushi Mukai, Keiko Morikawa, Toshihiro Ichiki, Shosuke Takahashi, Akira Takeshita, Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II–Induced Cardiovascular Hypertrophy in Rats In Vivo Effect on Endothelial NAD(P)H Oxidase System Circulation Research. ,vol. 93, pp. 767- 775 ,(2003) , 10.1161/01.RES.0000096650.91688.28
Tammy M. Seasholtz, Tong Zhang, Michael R. Morissette, Amy L. Howes, Amy H. Yang, Joan Heller Brown, Increased Expression and Activity of RhoA Are Associated With Increased DNA Synthesis and Reduced p27Kip1 Expression in the Vasculature of Hypertensive Rats Circulation Research. ,vol. 89, pp. 488- 495 ,(2001) , 10.1161/HH1801.096337
HARRY P. KOO, TIMOTHY E. BUNCHMAN, JOSEPH T. FLYNN, JEFFREY D. PUNCH, ANNE C. SCHWARTZ, DAVID A. BLOOM, RENAL TRANSPLANTATION IN CHILDREN WITH SEVERE LOWER URINARY TRACT DYSFUNCTION The Journal of Urology. ,vol. 161, pp. 240- 245 ,(1999) , 10.1016/S0022-5347(01)62119-0
Jacqueline Alblas, Laurien Ulfman, Peter Hordijk, Leo Koenderman, Activation of RhoA and ROCK Are Essential for Detachment of Migrating Leukocytes Molecular Biology of the Cell. ,vol. 12, pp. 2137- 2145 ,(2001) , 10.1091/MBC.12.7.2137
Amanda M. G. Versteilen, Iolente J. M. Korstjens, René J. P. Musters, A. B. Johan Groeneveld, Pieter Sipkema, Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney American Journal of Physiology-renal Physiology. ,vol. 291, ,(2006) , 10.1152/AJPRENAL.00434.2005
Bengt Fellström, Hallvard Holdaas, Alan G Jardine, Gudrun Nyberg, Carola Grönhagen-Riska, Søren Madsen, Hans-Hellmut Neumayer, Edward Cole, Bart Maes, Patrice Ambühl, Anders G Olsson, Beatrix Staffler, Terje R Pedersen, Assessment of Lescol in Renal Transplantation Study Investigators, Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation. ,vol. 79, pp. 205- 212 ,(2005) , 10.1097/01.TP.0000147338.34323.12
Tsuyoshi Hattori, Hiroaki Shimokawa, Midoriko Higashi, Junko Hiroki, Yasushi Mukai, Kozo Kaibuchi, Akira Takeshita, Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice Circulation Research. ,vol. 94, pp. 46- 52 ,(2004) , 10.1161/01.RES.0000107196.21335.2B
Bruce A. Perkins, Linda H. Ficociello, Betsy E. Ostrander, Kristen H. Silva, Janice Weinberg, James H. Warram, Andrzej S. Krolewski, Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes Journal of The American Society of Nephrology. ,vol. 18, pp. 1353- 1361 ,(2007) , 10.1681/ASN.2006080872